| Dr Penny Kaye Jensen, FNP-C | |
|
Salt Lake Veterans Affairs Healhcare, 500 Foothill Drive, Salt Lake City, UT 84148-0001 | |
| (801) 582-1565 | |
| (801) 584-2503 |
| Full Name | Dr Penny Kaye Jensen |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Location | Salt Lake Veterans Affairs Healhcare, Salt Lake City, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023081452 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 2170254405 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Penny Kaye Jensen, FNP-C 500 Foothill Drive, Salt Lake City Va Healthcare System, Salt Lake City, UT 84148-2415 Ph: (801) 582-1565 | Dr Penny Kaye Jensen, FNP-C Salt Lake Veterans Affairs Healhcare, 500 Foothill Drive, Salt Lake City, UT 84148-0001 Ph: (801) 582-1565 |
News Archive
Elsevier, the leading publisher of scientific, technical and medical information, today announced it is celebrating medical education innovation at the American Medical Student Association's 60th Annual Convention, March 11-14, 2010, at the Disneyland Hotel in Anaheim, California.
A study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) has identified an abnormal metabolic pathway that drives cancer-cell growth in a particular glioblastoma subtype. The finding might lead to new therapies for a subset of patients with glioblastoma, the most common and lethal form of brain cancer.
Many people across the globe are working hard to get the better of cancer; however cancer is always working too. Cancer cells can become resistant to the methods that have been adopted to kill them, so identifying drugs that act in different ways is part of the push to outsmart this ubiquitous disease
Yale Cancer Center scientists have found that combining the targeted drug trastuzumab with chemotherapy significantly improves survival rates for women with a rare, aggressive form of endometrial cancer.
Zylast products have been selected as one of only three initial winners of the USAID Fighting Ebola Grand Challenge. The announcement, made from the White House, introduces Zylast as a solution to "help healthcare workers on the front lines provide better care and stop the spread of Ebola."
› Verified 7 days ago
Mrs. Lisa Ann Runyon, CPNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 100 N Medical Dr, Trauma Services, Salt Lake City, UT 84113 Phone: 801-662-2993 Fax: 801-662-2999 | |
Donna M. Wahoff-stice, APRN, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 615 Arapeen Dr, 100, Salt Lake City, UT 84108 Phone: 801-581-7761 | |
Linda M Lambert, A.P.R.N. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 100 N Medical Dr, Salt Lake City, UT 84113 Phone: 801-662-1000 | |
Ms. Ann A. K. Kamp, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 100 N Medical Dr, Salt Lake City, UT 84113 Phone: 801-662-1000 Fax: 801-662-4166 | |
Sarah Zobell, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 100 Mario Capecchi Dr, Salt Lake City, UT 84113 Phone: 801-662-1619 | |
Mrs. Giovana Martendal King, NNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 100 Mario Capecchi Dr, Salt Lake City, UT 84113 Phone: 801-662-4100 | |
Alicia Donaldson, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 100 N Mario Capecchi Dr, Salt Lake City, UT 84113 Phone: 801-662-1000 |